New ICD-10-CM Codes in 2025 - Page 3

261 codes were added to the 2025 ICD-10-CM code set, effective October 1, 2024.

  • M65.951 - Unspecified synovitis and tenosynovitis, right thigh
  • M65.952 - Unspecified synovitis and tenosynovitis, left thigh
  • M65.959 - Unspecified synovitis and tenosynovitis, unspecified thigh
  • M65.96 - Unspecified synovitis and tenosynovitis, lower leg
  • M65.961 - Unspecified synovitis and tenosynovitis, right lower leg
  • M65.962 - Unspecified synovitis and tenosynovitis, left lower leg
  • M65.969 - Unspecified synovitis and tenosynovitis, unspecified lower leg
  • M65.97 - Unspecified synovitis and tenosynovitis, ankle and foot
  • M65.971 - Unspecified synovitis and tenosynovitis, right ankle and foot
  • M65.972 - Unspecified synovitis and tenosynovitis, left ankle and foot
  • M65.979 - Unspecified synovitis and tenosynovitis, unspecified ankle and foot
  • M65.98 - Unspecified synovitis and tenosynovitis, other site
  • M65.99 - Unspecified synovitis and tenosynovitis, multiple sites
  • Q23.81 - Bicuspid aortic valve
  • Q23.82 - Congenital mitral valve cleft leaflet
  • Q23.88 - Other congenital malformations of aortic and mitral valves
  • Q87.86 - Kleefstra syndrome
  • R41.85 - Anosognosia
  • T45.A - Poisoning by, adverse effect of and underdosing of immune checkpoint inhibitors and immunostimulant drugs
  • T45.AX - Poisoning by, adverse effect of and underdosing of immune checkpoint inhibitors and immunostimulant drugs
  • T45.AX1 - Poisoning by immune checkpoint inhibitors and immunostimulant drugs, accidental (unintentional)
  • T45.AX2 - Poisoning by immune checkpoint inhibitors and immunostimulant drugs, intentional self-harm
  • T45.AX3 - Poisoning by immune checkpoint inhibitors and immunostimulant drugs, assault
  • T45.AX4 - Poisoning by immune checkpoint inhibitors and immunostimulant drugs, undetermined
  • T45.AX5 - Adverse effect of immune checkpoint inhibitors and immunostimulant drugs
  • T45.AX6 - Underdosing of immune checkpoint inhibitors and immunostimulant drugs
  • T81.320 - Disruption or dehiscence of gastrointestinal tract anastomosis, repair, or closure
  • T81.321 - Disruption or dehiscence of closure of internal operation (surgical) wound of abdominal wall muscle or fascia
  • T81.328 - Disruption or dehiscence of closure of other specified internal operation (surgical) wound
  • T81.329 - Deep disruption or dehiscence of operation wound, unspecified
  • Z15.1 - Genetic susceptibility to epilepsy and neurodevelopmental disorders
  • Z15.2 - Genetic susceptibility to obesity
  • Z17.2 - Progesterone receptor status
  • Z17.21 - Progesterone receptor positive status
  • Z17.22 - Progesterone receptor negative status
  • Z17.3 - Human epidermal growth factor 2 receptor
  • Z17.31 - Human epidermal growth factor receptor 2 positive status
  • Z17.32 - Human epidermal growth factor receptor 2 negative status
  • Z17.4 - Combined receptor status
  • Z17.41 - Hormone receptor positive
  • Z17.410 - Hormone receptor positive with human epidermal growth factor receptor 2 positive status
  • Z17.411 - Hormone receptor positive with human epidermal growth factor receptor 2 negative status
  • Z17.42 - Hormone receptor negative
  • Z17.420 - Hormone receptor negative with human epidermal growth factor receptor 2 positive status
  • Z17.421 - Hormone receptor negative with human epidermal growth factor receptor 2 negative status
  • Z51.A - Encounter for sepsis aftercare
  • Z59.71 - Insufficient health insurance coverage
  • Z59.72 - Insufficient welfare support
  • Z67.A - Duffy phenotype
  • Z67.A1 - Duffy null
  • Z67.A2 - Duffy a positive
  • Z67.A3 - Duffy b positive
  • Z67.A4 - Duffy a and b positive
  • Z68.55 - Body mass index [BMI] pediatric, 120% of the 95th percentile for age to less than 140% of the 95th percentile for age
  • Z68.56 - Body mass index [BMI] pediatric, greater than or equal to 140% of the 95th percentile for age
  • Z83.72 - Family history of familial adenomatous polyposis
  • Z86.0100 - Personal history of colon polyps, unspecified
  • Z86.0101 - Personal history of adenomatous and serrated colon polyps
  • Z86.0102 - Personal history of hyperplastic colon polyps
  • Z86.0109 - Personal history of other colon polyps
  • Z92.26 - Personal history of immune checkpoint inhibitor therapy